GL1X · GenesisL1 explorer

MolNFT v1 · #335487 · protein

P18754: AlphaFold monomer V2.0 prediction for regulator of chromosome condensation (P18754)

P18754: “AlphaFold monomer V2.0 prediction for regulator of chromosome condensation (P18754)”. 2 pockets (best druggability 0.78). MolNFT v1 #335487 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

3D structure of P18754: AlphaFold monomer V2.0 prediction for regulator of chromosome condensation (P18754) (MolNFT v1 / AlphaFold)
3D structure of P18754: AlphaFold monomer V2.0 prediction for regulator of chromosome condensation (P18754) (MolNFT v1 / AlphaFold)
Accession
P18754
Type
protein
Length
421 residues
Chains
1
Deposited
01-JUL-21
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x7c75F0f7d6d136A2b8D4C6C6e9b3D8a697949DF1
Molecule
Regulator of chromosome condensation
UniProt
P18754
Pockets
2 · best druggability 0.78

Structure

1 distinct chain · 4% helix, 41% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARegulator of chromosome condensationprotein4214% helix, 41% strandP18754

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15970.780.8460empty
2630.310.7517empty

Compared structures

  • 5TBK · Crystal structure of human importin A3 bound to RCC1 · an experimental structure of the same protein · chain A against K, TM-score 0.95
  • 5TBK · Crystal structure of human importin a3 bound to RCC1 · an experimental structure of the same protein · chain A against K, TM-score 0.95
  • 8UX1 · Cryo-EM structure of Ran bound to RCC1 and the nucleosome core particle · an experimental structure of the same protein · chain A against L, TM-score 0.94
  • 1A12 · Regulator of chromosome condensation (RCC1) of human · an experimental structure of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.